The simple rule to calculate safe dose of contrast to be used over ULC PCI based on GFR that we always use. bit.ly/3soK7GV ⁦Ziad Ali⁩

End stage renal disease is not CKD. Look at the difference in prognosis. Protect you patient from acute kidney injury over PCI. ⁦Ziad Ali⁩ at our course in Madrid bit.ly/3soK7GV

Sources of risk in PCI. Dejan Milasinovic bit.ly/3soK7GV

Not all coronary calcific nodules are the same: great discussion bu Ziad Ali at bit.ly/3soK7GV

Flavio Ribichini discussing key aspects of PCI in patients with heavily calcific vessels (here highlighting the importance of LV function in planning safe PCI) bit.ly/3soK7GV

Great debate on bifurcation PCI and messages for fellows by Goran Stankovic, MD, PhD in Madrid bit.ly/3soK7GV

Congratulations Annette! 🏆 Well deserved 2022 EAPCI Fellowship!

Congratulations Andrija! 2022 EAPCI Fellowship Awardee 🏆

Great news! Congratulations to Claudio and all 2022 EAPCI Fellowship Grant Awardees!

The study by Rocco Montone et al bit.ly/3MjUh55 , based on real life clinical practice supports the safety and clinical value of acetylcholine testing in INOCA and MINOCA. Highly recommended. INOCA INTERNATIONAL International Heart Spasms Alliance ACI-SEC: Hemodinamica PCRonline 🫀
twitter.com/RoccoMontone/s…

Por fin hemos vuelto. Muchísimas gracias a todos por seguir aquí.

One of the most rewarding and fulfilling aspects of our life as physicians / researchers is to share the professional journey with our fellows. In this occasion, time to think also in my late friend Prof David Foley, who sent Angela McInerney to me. #somosclinico Complutense

samitshahmd Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Javier Escaned Richard Sohn Ziad Ali Tom Ford Jacqueline Saw Less-Is-More Cardiologist Aish Sinha As said in the TCT symposium this week, diagnosis is key

No one wants patients to suffer for years on end if a diagnosis can be made and help offered.

Linking to our paper just published in IJC. It makes for very sobering reading.

sciencedirect.com/science/articl…